United States Minimally Invasive Surgery Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

The United States Minimally Invasive Surgery Devices market was valued at USD 7.09 Billion in 2025. It is poised to grow at a CAGR of 6.10% during the forecast period of 2026-2035, and reach USD 12.82 Billion by 2035. The market growth is driven by the increasing prevalence of chronic and lifestyle-related disorders, such as cardiovascular diseases, cancer, and orthopaedic conditions, along with the rising adoption of image-guided surgery and precision surgery technologies.

Key Market Trends and Insights

• Based on product type, the robotic-assisted surgery segment held 33% in the historical period.
• By application, the gynecological surgery segment recorded the highest share of approximately 33% in the historical period.
• Based on the end user, the hospital's end-use segment accounted for nearly 55% in the historical period.

Market Size and Forecast

• Market Size (2025) : USD 7.09 Billion
• Projected Market Size (2035) : USD 12.82 Billion
• CAGR (2026-2035) : 6.10%

United States Minimally Invasive Surgery Devices Market Overview

Minimally invasive surgery devices include specialized instruments and platforms that enable surgeons to perform procedures through small incisions or natural orifices, reducing tissue trauma, hospital stays, and recovery time. The United States market was valued at USD 7.09 Billion in 2025, The market demonstrates strong growth, driven by high procedure volumes, rapid adoption of innovative surgical technologies, and increasing preference for less invasive treatment options across hospitals and specialty clinics. The rising prevalence of chronic diseases, the expanding elderly population, and continuous investments in healthcare infrastructure further strengthen market expansion, while favorable reimbursement policies encourage widespread clinical adoption. Additionally, the adoption of enhanced recovery protocols and minimally invasive treatment pathways is improving patient outcomes and hospital efficiency.

United States Minimally Invasive Surgery Devices Market Growth Drivers

Rising Advancements in Surgical Energy Devices to Boost Innovation in the Market

The adoption of advanced surgical energy systems is a key factor driving the growth in the market. For example, in March 2025, Johnson & Johnson MedTech launched the DUALTO™ Energy System, integrating monopolar, bipolar, ultrasonic, and advanced bipolar energy modalities into a single platform. The system reduces operating room footprint by up to 46% and supports precise energy delivery through Adaptive Tissue Technology. With FDA 510(k) clearance and compatibility with the Polyphonic™ Fleet digital ecosystem, DUALTO enhances workflow efficiency and usability, demonstrating how technological innovation, alongside advanced energy-based devices and intraoperative imaging systems, is expected to drive significant market growth in minimally invasive surgery.

United States Minimally Invasive Surgery Devices Market Trends

Some of the notable trends in the market are rapid advancements in robotic precision and the expanding adoption of robotic-assisted surgery.

Increasing Advancements in Robotic Precision to Boost the Market Demand

The market is witnessing significant growth driven by innovations in robotic-assisted surgery. For instance, in September 2025, Virtuoso Surgical, Inc., a Nashville-based company, announced that its Virtuoso surgical robotic system received FDA Breakthrough Device Designation for bladder lesion removal via en bloc excision. The system’s needle-sized robotic arms provide unprecedented dexterity and precision in rigid endoscopic procedures, enhancing diagnostic accuracy and improving patient outcomes. Such technological advancements are expanding the adoption of minimally invasive techniques across surgical specialties, thereby bolstering overall market growth and shaping the future of surgical care.

United States Minimally Invasive Surgery Devices Market Segmentation

Market Breakup by Product Type

• Handheld Instruments
• Guiding Devices
• Guiding Catheters
• Guidewires
• Electrosurgical Devices
• Endoscopic Devices
• Laparoscopic Devices
• Monitoring & Visualization Devices
• Ablation Devices
• Laser-Based Devices
• Robotic Assisted Surgical Systems
• Others

Market Breakup by Application

• Aesthetics
• Cardiovascular
• Gastrointestinal
• Gynecological
• Orthopedic
• Urological
• Neurological
• Others

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

United States Minimally Invasive Surgery Devices Market Share

Robotic Assisted Surgical Systems are Expected to Lead the Market Segmentation by Product Type

The market is segmented by product type into handheld instruments, guiding devices such as guiding catheters and guidewires, electrosurgical devices, endoscopic devices, laparoscopic devices, monitoring and visualization devices, ablation devices, laser-based devices, robotic-assisted surgical systems, and others. Among these, robotic-assisted surgical systems are expected to lead due to their precision, efficiency, and expanding clinical applications, robotic navigation systems and minimally invasive imaging technologies. For instance, in February 2024, Virtual Incision received FDA authorization for its miniaturized MIRA Surgical System, enhancing access to robotic-assisted procedures. This innovation supports wider adoption and sustained market growth.

Leading Players in the United States Minimally Invasive Surgery Devices Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Abbott

Abbott strengthened its minimally invasive structural heart portfolio in May 2025 with FDA approval of the Tendyne transcatheter mitral valve replacement system for patients with severe mitral annular calcification. In December 2025, the company also secured FDA approval for the Volt Pulsed Field Ablation System, treating atrial fibrillation through a minimally invasive catheter-based approach, reinforcing advancements in catheter-based interventions.

Medtronic plc

Medtronic is a key player in the United States robotic surgery market. In December 2025, the FDA cleared its Hugo robotic-assisted surgery system for urologic procedures. The company offers a broad range of advanced technologies, including energy-based surgical devices, surgical stapling systems, trocars and access instruments, ultrasonic dissection tools, vessel sealing solutions, and visualization systems.

Boston Scientific Corporation

Boston Scientific sharpened its cardiovascular minimally invasive portfolio through targeted acquisitions. In January 2025, the company announced an agreement to acquire Bolt Medical to add advanced laser-based intravascular lithotripsy technology for coronary and peripheral artery disease. Its minimally invasive devices support vessel diagnosis, lesion preparation, and treatment precision. Boston Scientific also strengthens clinical adoption through its EDUCARE medical education platform, reinforcing its active involvement in the market.

Intuitive Surgical Inc.

IIntuitive Surgical Inc. is a leading innovator in the Minimally Invasive Surgery Devices Market, transforming surgical care since 1995 through advanced robotic-assisted technologies. The company’s portfolio includes the da Vinci SP system for single-port procedures, the newly developed da Vinci 5 surgical platform, and the Ion robotic bronchoscopy suite for minimally invasive lung biopsies. Intuitive also offers precision surgical instruments, digital solutions such as My Intuitive, and simulation-based training tools, supporting improved clinical outcomes and surgical efficiency worldwide.

Other key players in the market are Johnson & Johnson (Ethicon), Stryker Corporation, Olympus Corporation, Koninklijke Philips N.V., Smith & Nephew plc., and Zimmer Biomet.

Key Questions Answered in the United States Minimally Invasive Surgery Devices Market Report

• What was the United States minimally invasive surgery devices market value in 2025?
• What is the United States minimally invasive surgery devices market forecast outlook for 2026-2035?
• What major factors aid the demand for the United States minimally invasive surgery devices market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major United States minimally invasive surgery devices market trends?
• Which product type is expected to dominate the market segment?
• Which application is projected to lead the market segment?
• Which end user is anticipated to drive the market segment?
• Who are the key players in the United States minimally invasive surgery devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?